Abdullah Kilic, MD

IM Resident, Mountainside Medical Center NJ | 🫀 Aspiring Cardiologist | Traveller 🇹🇷

[Abdullah Kilic, MD @sarmisakkafa]

☕ DECAF Trial (JAMA 2025): In coffee drinkers with persistent AF post-cardioversion, continuing caffeinated coffee (avg 1 cup/day) reduced AF/flutter recurrence vs. abstinence (47% vs. 64%; HR 0.61, P=0.01). Challenges old advice!
Moderate intake may be OK for some.
#CardioTwitter #MedEd #AtrialFibrillation

[Annals of Internal Medicine: Clinical Cases @AnnalsofIMCC]

A 62-year-old woman experienced recurrent fainting episodes, double vision, eyelid drooping, and weakness. Although her blood pressure appeared normal and MRI showed no acute stroke, her symptoms were caused by vertebrobasilar hypoperfusion from severe aortic stenosis and bilateral vertebral artery stenosis. Read the full text for free here: https://t.co/A7jd90sHxM @AHAScience #AHAJournals @sarmisakkafa

[Abdullah Kilic, MD @sarmisakkafa]

Starting off #ACC26 Day 2 with heart-pumping exercise! 🏃‍♂️ @CardioNerds 5K pre-conference workout crushed 💓

Huge thanks to @CardioNerds, @AmitGoyalMD, and @RawanAAmir for organizing this epic start! #CardioNerds5k

[Abdullah Kilic, MD @sarmisakkafa]

Proud to present our innovation at #ACC26!
What an inspiring scientific meeting — surrounded by cardiologists, late-breaking trials, and the latest advances in cardiovascular medicine. Truly an amazing weekend #ACC2026 #NOLA #Cardiology

[Abdullah Kilic, MD @sarmisakkafa]

@drozgeozden Congratulations

[Abdullah Kilic, MD @sarmisakkafa]

Excellent new editorial in @CircIntv by @Irene_Santos_P & @mmamas1973:

“Clopidogrel Versus Aspirin Beyond 30 Days: Different Drugs, Same Outcomes?”

Thoughtful commentary on STOP-DAPT3 OAC subgroup—landmark analysis shows similar bleeding (HR 1.02) and cardiovascular event rates (HR 1.00) with clopidogrel vs aspirin monotherapy beyond 30 days post-PCI.

A must-read!
🔗 https://t.co/i1VF3exoKe
#Cardiology #InterventionalCardiology #PCI #DAPT #CardioTwitter

@SVRaoMD @mirvatalasnag @HirotWatanabeMD

[Abdullah Kilic, MD @sarmisakkafa]

Excellent new editorial in @CircIntv by @Irene_Santos_P & @mmamas1973:

“Clopidogrel Versus Aspirin Beyond 30 Days: Different Drugs, Same Outcomes?”

Thoughtful commentary on STOP-DAPT3 OAC subgroup—landmark analysis shows similar bleeding (HR 1.02) and cardiovascular event rates (HR 1.00) with clopidogrel vs aspirin monotherapy beyond 30 days post-PCI.

A must-read!
🔗 https://t.co/i1VF3exoKe
#Cardiology #InterventionalCardiology #PCI #DAPT #CardioTwitter

@SVRaoMD @mirvatalasnag @HirotWatanabeMD

[Abdullah Kilic, MD @sarmisakkafa]

🫀 Rhythm Control Toolkit from @COREIMpodcast : Early rhythm control shows mortality & QoL benefits over rate control (EAST-AFNET 4). Key pearls: Electrical cardioversion as reset button for unstable/symptomatic pts; diagnostic value in unmasking symptoms. Catheter ablation 1st-line for paroxysmal AF or HFrEF on GDMT. #CardioTwitter #MedEd #AtrialFibrillation @HKnaussMD @ShreyaTrivediMD @DrRachitaEP @syang_md

[Abdullah Kilic, MD @sarmisakkafa]

🫀 New JAMA Cardio meta-analysis: In preserved EF (>50%) post-MI, β-blockers show NO benefit in mortality, CV death, recurrent MI, HF. Rethink routine use? #CardioTwitter #MedEd
https://t.co/BcFlw8ZAgv @JAMACardio

[Abdullah Kilic, MD @sarmisakkafa]

2024 FINEARTS-HF trial published in NEJM: In patients with HFpEF or HFmrEF (EF >40%), finerenone—a nonsteroidal mineralocorticoid receptor antagonist—significantly reduced the composite endpoint of worsening heart failure events and CV death compared to placebo (rate ratio 0.84, P=0.007). Key wins: Fewer HF hospitalizations (rate ratio 0.82) and better potassium balance. #HeartFailure #Cardiology #HFpEF #MedTwitter

@mvaduganathan

[Abdullah Kilic, MD @sarmisakkafa]

2024 FINEARTS-HF trial published in NEJM: In patients with HFpEF or HFmrEF (EF >40%), finerenone—a nonsteroidal mineralocorticoid receptor antagonist—significantly reduced the composite endpoint of worsening heart failure events and CV death compared to placebo (rate ratio 0.84, P=0.007). Key wins: Fewer HF hospitalizations (rate ratio 0.82) and better potassium balance. #HeartFailure #Cardiology #HFpEF #MedTwitter

@mvaduganathan

[Abdullah Kilic, MD @sarmisakkafa]

Have you ever seen this? In 1952, amid early claims linking smoking to cancer, Kent cigarettes introduced the “Micronite” filter—marketed as the ultimate health protection. The irony? It contained asbestos, releasing millions of carcinogenic fibers per cigarette!

From 1952-1956, over 13B were sold, leading to mesothelioma & lung cancer risks. A deadly “safety” gimmick! #CardioTwitter #MedEd #SmokingHistory #MondayMotivation #MondayMorning

[American College of Cardiology @ACCinTouch]

In patients with type 2 diabetes treated with ICDs, the arrhythmic effect of empagliflozin appears more pronounced in men than in women, according to a subanalysis of the EMPA-ICD trial published in #JACCAsia.

Learn more: https://t.co/aPzvDFS0kl #epICD #cvEP @JACCJournals

[Abdullah Kilic, MD @sarmisakkafa]

☕ DECAF Trial (JAMA 2025): In coffee drinkers with persistent AF post-cardioversion, continuing caffeinated coffee (avg 1 cup/day) reduced AF/flutter recurrence vs. abstinence (47% vs. 64%; HR 0.61, P=0.01). Challenges old advice!
Moderate intake may be OK for some.
#CardioTwitter #MedEd #AtrialFibrillation

[Abdullah Kilic, MD @sarmisakkafa]

@docHJ @JAMACardio Thank you 🙏

[Abdullah Kilic, MD @sarmisakkafa]

🫀 New JAMA Cardio meta-analysis: In preserved EF (>50%) post-MI, β-blockers show NO benefit in mortality, CV death, recurrent MI, HF. Rethink routine use? #CardioTwitter #MedEd
https://t.co/BcFlw8ZAgv @JAMACardio

[Abdullah Kilic, MD @sarmisakkafa]

@docHJ Congratulations Dr Jneid

[Abdullah Kilic, MD @sarmisakkafa]

Gordon Ramsey vs William Osler

[Abdullah Kilic, MD @sarmisakkafa]

Antiarrhythmics monitoring: Sotalol/Dofetilide (no CKD): Watch QTc, electrolytes, torsades. Flecainide/Propafenone (no structural HD): Stress EKG for QRS widening, add rate control to avoid 1:1 flutter. Amiodarone: PFTs/LFTs/TFTs for toxicity. Success varies case-by-case. Thanks @COREIMpodcast for this gem! #Cardiology #MedTwitter

[Abdullah Kilic, MD @sarmisakkafa]

🫀 Rhythm Control Toolkit from @COREIMpodcast : Early rhythm control shows mortality & QoL benefits over rate control (EAST-AFNET 4). Key pearls: Electrical cardioversion as reset button for unstable/symptomatic pts; diagnostic value in unmasking symptoms. Catheter ablation 1st-line for paroxysmal AF or HFrEF on GDMT. #CardioTwitter #MedEd #AtrialFibrillation @HKnaussMD @ShreyaTrivediMD @DrRachitaEP @syang_md